Studies implicate only gestodene and desogestrel

BMJ 1995; 311 doi: 10.1136/bmj.311.7020.1639b (Published 16 December 1995)
Cite this as: BMJ 1995;311:1639.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. R J Donnelly, Medical director Janssen-Cilag, Saunderton, High Wycombe
  1. Buckinghamshire HP14 4HJ

    EDITOR,--The Committee on Safety of Medicines' advice to the profession on combined oral contraceptives led to two editorials1 2 and three other items. …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL